Characterization of Ustekinumab-Associated Infections in Patients with moderate to severe Plaque-Psoriasis

被引：0
|
作者：
Leonardi, C. [1 ]
Guenther, L. [2 ]
Wasel, N. [3 ]
Yeilding, N. [4 ]
Szapary, P. O. [4 ]
Hsu, M-C [4 ]
Reich, K. [5 ]
机构：
[1] Dept Dermatol, St Louis, MO USA
[2] Guenther Dermatol Res Ctr, London, ON, Canada
[3] Strat Med, Edmonton, AB, Canada
[4] Centocor Res & Dev, Malvern, PA USA
[5] SCIderm GmbH, Hamburg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：194 / 195
页数：2
相关论文
共 50 条
  • [1] Characterization of infections associated with ustekinumab in moderate to severe psoriasis patients
    Leonardi, C.
    Guenther, L.
    Wasel, N.
    Yeilding, N.
    Szapary, P. O.
    Hsu, M. C.
    Langley, R. G.
    Reich, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 22 - 22
  • [2] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Dauden, E.
    Prieto-Perez, R.
    Llamas-Velasco, M.
    Cabaleiro, T.
    Abad-Santos, F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S188 - S188
  • [3] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Prieto-Perez, Rocio
    Llamas-Velasco, Mar
    Cabaleiro, Teresa
    Solano-Lopez, Guillermo
    Marquez, Beatriz
    Roman, Manuel
    Ochoa, Dolores
    Talegon, Maria
    Dauden, Esteban
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2017, 18 (02) : 157 - 164
  • [4] Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis
    Croxtall, Jamie D.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2012, 13 (02) : 135 - 137
  • [5] Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis
    Jamie D. Croxtall
    American Journal of Clinical Dermatology, 2012, 13 : 135 - 137
  • [6] Ustekinumab improves quality of life in Japanese patients with moderate to severe plaque psoriasis
    Nakagawa, H.
    Kato, T.
    Kato, M.
    Igarashi, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 18 - 18
  • [7] Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis
    Fioranelli, Massimo
    Roccia, Maria Grazia
    Lotti, Torello
    DERMATOLOGIC THERAPY, 2017, 30 (05)
  • [8] Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
    Papp, Kim A.
    Blauvelt, Andrew
    Bukhalo, Michael
    Gooderham, Melinda
    Krueger, James
    Lacour, Jean-Philippe
    Menter, Alan
    Philipp, Sandra
    Sofen, Howard
    Tyring, Stephen
    Berner, Beate R.
    Visvanathan, Sudha
    Pamulapati, Chandrasena
    Bennett, Nathan
    Flack, Mary
    Scholl, Paul
    Padula, Steven J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (16): : 1551 - 1560
  • [9] Comparison of ustekinumab (UST) and etanercept (ETA) in the treatment of moderate to severe plaque-psoriasis: a multicentric, random phase 3-study
    Luger, T. A.
    Griffiths, C.
    Strober, B.
    Van de Kerkhof, P. C.
    Ho, V
    Guzzo, C.
    Yeilding, N.
    Fidelus-Gort, R.
    Zhou, B.
    Xia, K.
    Menter, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 205 - 206
  • [10] Ustekinumab A Review of its Use in the Management of Moderate To Severe Plaque Psoriasis
    Croxtall, Jamie D.
    DRUGS, 2011, 71 (13) : 1733 - 1753
12345